| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.08M | $6.93M | - | |
| VP | 300.8K | $1.93M | - | |
| CFO | 295.3K | $900.7K | - | |
| Other | 189.4K | $1.22M | - | |
| Other | 100.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2017 | Tepper Robert I | 10% Owner | Sell | 20,000 | $18.00 | $360,000.00 | -26.9% | |
| Sep 1, 2017 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $17.17 | $42,925.00 | -12.7% | |
| Sep 1, 2017 | McCarthy Sean A.68 | President and CEO | Sale+OE | 9,930 | $17.32 | $171,987.60 | -70.1% | |
| Aug 31, 2017 | McCarthy Sean A.68 | President and CEO | Sale+OE | 18,756 | $17.50 | $328,260.00 | -81.5% | |
| Aug 9, 2017 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $15.00 | $37,500.00 | -11.3% | |
| Aug 9, 2017 | McCarthy Sean A.68 | President and CEO | Sale+OE | 4,781 | $15.00 | $71,715.00 | -53.0% | |
| Jul 3, 2017 | McCarthy Sean A.68 | President and CEO | Sale+OE | 4,781 | $15.52 | $74,201.12 | -53.0% | |
| Jul 3, 2017 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $15.47 | $38,675.00 | -10.2% | |
| Jun 29, 2017 | Tepper Robert I | 10% Owner | Sell | 15,000 | $16.00 | $240,000.00 | -25.1% | |
| Jun 26, 2017 | Gluck Frederick W | Director | Sell | 5,000 | $14.61 | $73,050.00 | -1.5% |